Checkmate Pharmaceuticals Inc (CMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CMPI | AZN | AMGN | GILD | VRTX |
| Company | Checkmate Pharmaceuticals Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 10.49 | 90.37 | 329.09 | 120.98 | 455.65 |
| High | 10.50 | 90.83 | 329.67 | 122.37 | 457.17 |
| Low | 10.48 | 89.67 | 321.62 | 120.59 | 439.80 |
| Latest | 10.50 | 90.85 | 321.66 | 120.99 | 440.81 |
| Change | +0.02 | +0.67 | -8.23 | -0.23 | -14.67 |
| % Change | +0.19% | +0.74% | -2.49% | -0.19% | -3.22% |
| Volume | 63,600 | 5,067,475 | 1,620,372 | 2,989,563 | 932,701 |
| 20-Day Average Volume | 283,120 | 5,488,185 | 2,827,278 | 6,819,385 | 1,390,392 |
| Previous Close | 10.48 | 90.18 | 329.89 | 121.22 | 455.48 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.43 | 90.13 | 337.59 | 124.46 | 434.61 |
| 20-Day Raw Stochastic | 100.00% | 57.59% | 9.74% | 33.97% | 58.99% |
| 20-Day Relative Strength | 87.35 | 60.13 | 49.79 | 47.86 | 56.02 |
| Weighted Alpha | -59.50 | +39.35 | +19.84 | +28.72 | -1.49 |
| Today's Opinion | 100% Buy | 100% Buy | 80% Buy | 80% Buy | 24% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 80% Buy | 80% Buy | 40% Buy |
| Last Month's Opinion | 88% Buy | 100% Buy | 56% Buy | 100% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.38% since 05/20/22 | +0.03% since 12/01/25 | -4.54% since 12/01/25 | -2.63% since 12/01/25 | +3.85% since 12/01/25 |
| Low | 10.47 on 05/23/22 | 89.68 on 12/08/25 | 321.62 on 12/08/25 | 120.38 on 12/05/25 | 424.06 on 12/02/25 |
| High | 10.50 on 05/27/22 | 91.28 on 12/03/25 | 346.38 on 12/03/25 | 125.60 on 12/03/25 | 463.85 on 12/03/25 |
| 1-Month | |||||
| %Chg | +1.06% since 04/27/22 | +7.06% since 11/07/25 | +0.61% since 11/07/25 | +1.87% since 11/07/25 | +7.94% since 11/07/25 |
| Low | 10.34 on 05/11/22 | 85.85 on 11/10/25 | 319.54 on 11/10/25 | 117.13 on 11/10/25 | 410.50 on 11/10/25 |
| High | 10.50 on 05/27/22 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +268.42% since 02/25/22 | +11.02% since 09/08/25 | +14.98% since 09/08/25 | +4.47% since 09/08/25 | +11.82% since 09/08/25 |
| Low | 2.41 on 04/18/22 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 10.50 on 05/27/22 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +193.30% since 11/26/21 | +24.25% since 06/06/25 | +10.96% since 06/06/25 | +7.65% since 06/06/25 | -1.89% since 06/06/25 |
| Low | 2.00 on 01/27/22 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 10.50 on 05/27/22 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 231,399 | 279,686,592 | 177,639,520 | 150,395,232 | 115,563,928 |
| Shares Outstanding, K | 22,038 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -61,410,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -15,870,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | -4.84 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 05/12/22 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 05/12/22 | 11/06/25 | 11/04/25 | 10/30/25 | 11/03/25 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 11/21/25 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.70 | 15.55 | 14.97 | 29.87 |